NASDAQ:ICLR

Icon (ICLR) Stock Price, News & Analysis

Icon logo
$191.40 -3.25 (-1.67%)
Closing price 11/16/2026 04:00 PM Eastern
Extended Trading
$191.30 -0.09 (-0.05%)
As of 11/16/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About Icon Stock (NASDAQ:ICLR)

Advanced

Key Stats

Today's Range
$188.55
▼
$196.32
50-Day Range
$158.34
▼
$215.48
52-Week Range
$66.57
▼
$219.04
Volume
826,218 shs
Average Volume
1.25 million shs
Market Capitalization
$14.66 billion
P/E Ratio
32.94
Dividend Yield
N/A
Price Target
$213.76
Consensus Rating
Moderate Buy

Company Overview

ICON plc is a global contract research organization (CRO) that provides outsourced development services to pharmaceutical, biotechnology, medical device and government organizations. Its work supports the development of medicines and other healthcare products from early research through clinical trials and regulatory submission.

The company’s services include clinical trial design and management, data management and biostatistics, regulatory support, laboratory services, medical imaging and patient recruitment. ICON also provides consulting and other services intended to help clients plan and carry out clinical development programs.

Founded in Dublin, Ireland, in 1990, ICON serves clients and conducts research across multiple regions worldwide. In 2021, it acquired PRA Health Sciences, another global clinical research organization, expanding its capabilities and reach.

AI Generated. May Contain Errors.

Icon Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
79th Percentile Overall Score

ICLR MarketRank™: 
3.92809498399 of 5 stars

Icon scored higher than 79% of companies evaluated by MarketBeat, and ranked 110th out of 877 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Icon has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 1 strong buy rating, 9 buy ratings, 9 hold ratings, and 1 sell rating.

  • Upside Potential

    Icon has a consensus price target of $213.76, representing about 11.7% upside from its current price of $191.40.

  • Amount of Analyst Coverage

    Icon has been the subject of 13 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about Icon's stock forecast and price target.
  • Earnings Growth

    Earnings for Icon are expected to grow by 9.47% in the coming year, from $9.71 to $10.63 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Icon is 32.94, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 24.92.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Icon is 32.94, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 33.38.

  • Price to Earnings Growth Ratio

    Icon has a PEG Ratio of 11.11. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Icon has a P/B Ratio of 1.61. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    5.54% of the float of Icon has been sold short.
  • Short Interest Ratio / Days to Cover

    Icon has a short interest ratio ("days to cover") of 1.69, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Icon has recently decreased by 20.02%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Icon does not currently pay a dividend.

  • Dividend Growth

    Icon does not have a long track record of dividend growth.

  • News Sentiment

    Icon has a news sentiment score of 0.56. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Healthcare companies.
  • News Coverage This Week

    MarketBeat has tracked 6 news articles for Icon this week, compared to 4 articles on an average week.
  • Search Interest

    5 people have searched for ICLR on MarketBeat in the last 30 days.
  • MarketBeat Follows

    3 people have added Icon to their MarketBeat watchlist in the last 30 days. This is an increase of 200% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Icon insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $6,514,252.00 in company stock.

  • Percentage Held by Insiders

    44.00% of the stock of Icon is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    95.61% of the stock of Icon is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Icon's insider trading history.
Receive ICLR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Icon and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

ICLR Stock News Headlines

OmniAb (NASDAQ:OABI) & Icon (NASDAQ:ICLR) Head to Head Comparison
ICON: 3 Key Takeaways for Long-Term Investors
My $247 scanner for $7
Bill Poulos is cutting the price of his $247 Instant Scanner to $7 for Black Friday. It's a one-time payment that covers a full year, with no subscription and no re-bills. Every night after the close, the scanner screens nearly a thousand of America's biggest stocks. It returns a short list of qualifying setups with the exact buy price next to each one. There's nothing to install. If you decide it's not for you, you get the $7 back and keep the scanner for the year.tc pixel
ICON to Participate at Upcoming Investor Conferences
Icon (NASDAQ:ICLR) CAO Sells 272 Shares of Stock
See More Headlines

ICLR Stock Analysis - Frequently Asked Questions

Icon's stock was trading at $182.22 at the beginning of 2026. Since then, ICLR stock has increased by 5.0% and is now trading at $191.40.

Icon Plc (NASDAQ:ICLR) issued its quarterly earnings data on Tuesday, October, 27th. The medical research company reported $2.66 EPS for the quarter, beating analysts' consensus estimates of $2.62 by $0.04. Icon's revenue for the quarter was down .9% on a year-over-year basis.
Read the conference call transcript
.

The following companies are subsidiaries of Icon: PRA Health Sciences, MedPass International, MeDiNova Research, MolecularMD, Mapi Group, Clinical Research Management, PMG Research, and others.

Icon's top institutional investors include Boston Partners (1.58%), Equity Investment Corp (1.08%), Stephens Investment Management Group LLC (1.01%) and Russell Investments Group Ltd. (0.66%). Insiders that own company stock include Barry Edward Balfe, Nigel Bernard John Clerkin, Ciaran Murray, Linda Grais, Ronan Martin Murphy, Eugene Pacelli Mccague, John Dr Climax, Emer Lyons and Anne Clem Whitaker.
View institutional ownership trends
.

Shares of ICLR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Icon investors own include NVIDIA (NVDA), Pfizer (PFE), Netflix (NFLX), Adobe (ADBE), Amgen (AMGN), Micron Technology (MU) and Advanced Micro Devices (AMD).

Company Calendar

Last Earnings
10/27/2026
Today
11/16/2026
Jefferies Global Healthcare Conference
11/17/2026
9th Annual Evercore ISI HealthCONx Conference
12/01/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Life Sciences Tools & Services
Sub-Industry
Life Sciences Tools & Services
Current Symbol
NASDAQ:ICLR
Previous Symbol
NASDAQ:ICLR
CIK
1060955
Employees
40,100
Year Founded
1990

Price Target and Rating

High Price Target
$268.00
Low Price Target
$100.00
Potential Upside/Downside
+11.7%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.50
Research Coverage
20 Analysts

Profitability

EPS (Trailing Twelve Months)
$5.81
Trailing P/E Ratio
32.94
Forward P/E Ratio
18.01
P/E Growth
11.11
Net Income
$229.34 million
Net Margins
5.45%
Pretax Margin
6.29%
Return on Equity
7.73%
Return on Assets
4.39%

Debt

Debt-to-Equity Ratio
0.37
Current Ratio
1.32
Quick Ratio
1.32

Sales & Book Value

Annual Sales
$8.25 billion
Price / Sales
1.78
Cash Flow
$16.08 per share
Price / Cash Flow
11.90
Book Value
$119.21 per share
Price / Book
1.61

Miscellaneous

Outstanding Shares
76,570,000
Free Float
42,878,000
Market Cap
$14.66 billion
Optionable
Optionable
Beta
1.19

Social Links

7 Stocks That Could Lead the Next Market Boom Cover

Tesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.

Get This Free Report

This page (NASDAQ:ICLR) was last updated on 11/16/2026 by MarketBeat.com Staff.
From Our Partners